Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended September 30, 2026 (Q2 FY26) and Half Year ended September 30, 2026

Nature of Filing / Announcement: Outcome of Board Meeting

Audit Opinion:

Clean (Limited Review Report conducted by statutory auditors found no material misstatements)

Key Financial Highlights [in Lakhs, except per share data]:

Standalone Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹2,492.81 (compared to ₹345.05 in Q2 FY25 - significant improvement)
  • Total Income: ₹2,526.76
  • Net Profit: ₹255.61 (compared to ₹1.01 in Q2 FY25 - significant improvement)
  • EPS: Basic ₹2.32, Diluted ₹2.32

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹4,215.34 (compared to ₹1,093.05 in H1 FY25 - significant improvement)
  • Total Income: ₹4,267.37
  • Net Profit: ₹425.76 (compared to ₹17.93 in H1 FY25 - significant improvement)
  • EPS: Basic ₹3.86, Diluted ₹3.86

Financial Position as at September 30, 2026:

  • Paid-up equity share capital: ₹1,102.00 (Face Value ₹10 each)
  • Other Equity excluding Revaluation Reserve: ₹2,701.78
  • Cash and cash equivalents: ₹219.34
  • Other Bank Balances: ₹1,073.72
  • Total Borrowings: ₹100.00 (Non-current)

Segment-wise Performance:

The company operates under a single reportable segment - Chemicals business.

Corporate Actions:

No dividend declarations, share splits, bonus issues, buybacks, or capital raising activities were announced.

Other Significant Information:

  • The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS)
  • The adoption of Ind AS did not have any material impact on the financial statements
  • Consolidated financial results are not applicable
  • Figures for corresponding previous periods have been restated/regrouped wherever necessary for comparability